Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte…
SAN CARLOS, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel…